Vitrolife Group
Per Pettersson currently serves as the Head of Group Business Control at Vitrolife Group since July 2022. With a robust background at Vitrolife from July 2013 to December 2023, Per held multiple positions including Finance Director and various roles in business intelligence and controlling. Per's earlier experience includes consultancy and auditing at Ernst & Young, where responsibilities spanned internal control review and financial auditing under Norwegian GAAP and IFRS. Prior to that, Per worked as a Business and Financial Advisor at SEB, focused on private banking clients. Per holds a Certificate from the Stanford Executive Program, a Master's degree in Auditing and Accounting from the University of Gothenburg, and a Bachelor's degree in Business/Managerial Economics from Linnaeus University.
This person is not in any teams
This person is not in any offices
Vitrolife Group
The Vitrolife Group is a world-leading global provider of medical devices and genetic testing services. Dedicated to the reproductive-health market since 1994, we have grown by focusing on product development, groundbreaking research, consistent quality control and acquisitions of innovative companies in the industry. In 2021, Vitrolife acquired Igenomix, a leader in reproductive genetic testing services primarly for IVF clinics. Together we are now the Vitrolife Group, a global leader in reproductive health focused on supporting our customers and patients worldwide to improve treatment outcomes – always with sustainability in mind. Based on science and advanced research capabilities, our aim is to deliver products and services for the entire reproductive-health journey, providing consistent performance and guaranteed quality. Currently, we are approximately 1,100 people worldwide headquartered in Gothenburg, Sweden. Our products and services are available in more than 125 countries, through our own presence in more than 25 countries and a vast network of distributors for the rest of the world. We are on a mission to be the leading global partner in reproductive health, striving for better treatment outcomes for patients.